Feb 15th, 2021
Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality
Originally published 3 Dec 2020 | Arteriosclerosis, Thrombosis, and Vascular Biology
Patients with coronavirus disease 2019 (COVID-19) have a high rate of thrombosis. We hypothesized that severe acute respiratory syndrome coronavirus 2 infection leads to induction of TF (tissue factor) expression and increased levels of circulating TF-positive extracellular vesicles (EV) that may drive thrombosis.
This complete article can be downloaded at: https://www.ahajournals.org/doi/10.1161/ATVBAHA.120.315547